Metabolic markers tied to increased risk of depression and anxiety, study finds

FHS
April 4, 2024
3:19 am

Comprehensive study within a large Swedish cohort links elevated glucose and triglyceride levels to an increased risk of developing depression, anxiety, and stress-related disorders, while higher HDL-C levels seem protective, suggesting a significant connection between metabolic health and psychiatric conditions.

Hormonal IUDs Linked to Increased Breast Cancer Risk

Women younger than 50 who used a levonorgestrel-releasing intrauterine device (IUD) had a significantly higher risk of breast cancer as compared with women who did

October 18, 2024

Which drugs are most likely to be approved in Mixed Pain (Nociceptive Pain/Neuropathic Pain)?

Mixed Pain (Nociceptive Pain/Neuropathic Pain) disease is an indication for drug development with over 270 pipeline drugs currently active according to GlobalData.

March 28, 2024

Myelofibrosis: Beyond Ruxolitinib

Up until fairly recently, ruxolitinib (Jakafi) was the only FDA-approved treatment for intermediate- and high-risk myelofibrosis, and thus has been the cornerstone of myelofibrosis treatment

June 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.